Paragon Wealth Strategies’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Paragon Wealth Strategies’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,000	Closed	-$217K	–	297
2021 Q1	$217K	Buy	+1,000	New	+$188K	0.07%	39

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Paragon Wealth Strategies's GWPH Position: Q2 2021 in Review

Paragon Wealth Strategies sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,000 shares — an estimated $217K sold.

Paragon Wealth Strategies first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $217K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Paragon Wealth Strategies reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Paragon Wealth Strategies sold 1,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $217K.
Paragon Wealth Strategies first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Paragon Wealth Strategies's GW Pharmaceuticals Plc American Depositary Shares position peaked at $217K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Paragon Wealth Strategies's 13F filing for Q2 2021, filed 12 Jul 2021.